| Thomas J Donnelly, MD | |
|
1520 S Main St, #2, Dayton, OH 45409-2698 | |
| (937) 461-5815 | |
| (937) 461-2896 |
| Full Name | Thomas J Donnelly |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 36 Years |
| Location | 1520 S Main St, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255323895 | NPI | - | NPPES |
| 000000012219 | Other | OH | ANTHEM BCBS |
| 4800316 | Other | OH | UNITED HEALTHCARE |
| 2017669 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35072508 (Ohio) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 35072508 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Upper Valley Medical Center | Troy, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary And Critical Care Consultants, Inc | 9234115379 | 34 |
News Archive
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
During a time of flux for U.S. health care, employers and purchasers are increasingly concerned about how much value they receive for their enormous investment in health care. In a presentation yesterday evening at the World Health Congress Innovative Drivers of Value Based Purchasing Seminar, Leah Binder, president and CEO of the employer-driven nonprofit The Leapfrog Group, unveiled a new tool that allows purchasers to calculate how much they spend annually on unnecessary costs due to medical errors that occur within general acute care hospitals.
Evotec AG today announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators of various protein-protein interaction targets.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A team of researchers is creating new information technology to help older adults with chronic heart failure. For the first time, researchers are capturing and working to empower individuals with their own heart health data.
› Verified 4 days ago
| Entity Name | Pulmonary & Critical Care Consultants, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861432379 PECOS PAC ID: 9234115379 Enrollment ID: O20040628001629 |
News Archive
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
During a time of flux for U.S. health care, employers and purchasers are increasingly concerned about how much value they receive for their enormous investment in health care. In a presentation yesterday evening at the World Health Congress Innovative Drivers of Value Based Purchasing Seminar, Leah Binder, president and CEO of the employer-driven nonprofit The Leapfrog Group, unveiled a new tool that allows purchasers to calculate how much they spend annually on unnecessary costs due to medical errors that occur within general acute care hospitals.
Evotec AG today announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators of various protein-protein interaction targets.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A team of researchers is creating new information technology to help older adults with chronic heart failure. For the first time, researchers are capturing and working to empower individuals with their own heart health data.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas J Donnelly, MD 1520 S Main St, #2, Dayton, OH 45409-2698 Ph: (937) 461-5815 | Thomas J Donnelly, MD 1520 S Main St, #2, Dayton, OH 45409-2698 Ph: (937) 461-5815 |
News Archive
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
During a time of flux for U.S. health care, employers and purchasers are increasingly concerned about how much value they receive for their enormous investment in health care. In a presentation yesterday evening at the World Health Congress Innovative Drivers of Value Based Purchasing Seminar, Leah Binder, president and CEO of the employer-driven nonprofit The Leapfrog Group, unveiled a new tool that allows purchasers to calculate how much they spend annually on unnecessary costs due to medical errors that occur within general acute care hospitals.
Evotec AG today announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators of various protein-protein interaction targets.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A team of researchers is creating new information technology to help older adults with chronic heart failure. For the first time, researchers are capturing and working to empower individuals with their own heart health data.
› Verified 4 days ago
Abraham Wei, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 128 E Apple St, 2nd Floor, Dayton, OH 45409 Phone: 937-208-2004 Fax: 937-208-8828 | |
Ratnam A Oza, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 S Main St, Ste. 203, Dayton, OH 45409 Phone: 937-222-0603 Fax: 937-222-7122 | |
Dr. Mohamed Elmouelhi, MD, PHD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4100 W.third St., Dayton Vamc (11c), Dayton, OH 45428 Phone: 937-268-6511 | |
Freesia Dhingra, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4100 W. Third St., Dayton, OH 45428 Phone: 937-268-6511 | |
James P Graham, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1520 S Main St, # 2, Dayton, OH 45409 Phone: 937-461-5815 Fax: 937-461-2896 | |
Ugochukwu Nwokoro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1735 Big Hill Rd, Dayton, OH 45439 Phone: 937-224-4325 Fax: 937-224-4327 | |
Dr. Howard M Gross, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8881 N Main St, Dayton, OH 45415 Phone: 937-293-1622 Fax: 937-245-6308 |